Home

Relief ACP

relief acp topbanner

 

Relief ACP

Relief from tooth sensitivity

Relief ACP formula combines the speed of chemical sensitivity relief from potassium nitrate with the profound, long-term relief of amorphous calcium phosphate and fluoride, which precipitates hydroxyapitite and fluorapatite, occluding the dentin tubules. This highly effective formula is ideal for patients who suffer from tooth sensitivity caused by gum recession, root exposure, post root planning, and whitening.
Visit the Philips Resource library to download procedure instructions, material data safety sheets, clinicals, and marketing materials.

Understanding ACP

 

Whitening with ACP means stronger teeth, greater comfort, better results and optimal compliance by your patients. Relief ACP comes with all Philips Zoom take-home kits and can be used as treatment several times daily by everyone, as it has no known allergens.

Benefits of ACP

 

  • Rebuilds enamel: The deposition of hydroxyapatite onto teeth rebuilds enamel and restores luster through the remineralization process.

 

  • Reduces sensitivity: Clinical tests comparing Philips Zoom NiteWhite ACP with a NiteWhite formula containing no ACP showed that 30% of patients who used NiteWhite with ACP experienced less sensitivity, with twice as many patients experiencing zero sensitivity.

 

  • Improves appearance: Tooth whiteners with ACP also improve the cosmetic appearance of teeth by restoring enamel luster to create a smoother, glossier appearance.

Relief ACP Starter Kit

Six filled gel syringes for 12 dual-arch applications and tray material for fabrication.
Relief ACP | Philips
Relief ACP

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.